Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Sep 14, 2008; 14(34): 5311-5315
Published online Sep 14, 2008. doi: 10.3748/wjg.14.5311
Published online Sep 14, 2008. doi: 10.3748/wjg.14.5311
Table 1 Patient characteristics
| Number of patients completing the protocol | 15 |
| Gender | |
| Male | 9 (60%) |
| Female | 6 (40%) |
| Age (yr) | |
| Mean (range) | 62.2 (50-73) |
| Tumor location | |
| Head | 7 (46.7%) |
| Head-Body | 1 (6.6%) |
| Body-Tail | 7 (46.7%) |
| Total radiation dose | |
| 40.0 Gy | 12 (80%) |
| 50.0 Gy | 1 (6.6%) |
| 50.4 Gy | 2 (13.4% |
| Response | |
| Complete response | 1 (6.6%) |
| Partial response | 4 (26.7%) |
| Stable disease | 9 (60 %) |
| Progressive disease | 1 (6.6%) |
| Cause of death | |
| Liver metastasis | 10 (66.7%) |
| Peritoneal metastasis | 3 (20%) |
- Citation: Igarashi H, Ito T, Kawabe K, Hisano T, Arita Y, Kaku T, Takayanagi R. Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer. World J Gastroenterol 2008; 14(34): 5311-5315
- URL: https://www.wjgnet.com/1007-9327/full/v14/i34/5311.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5311